Imaging Follow-Up of Nonsurgical Therapies for Lung Cancer : AJR Expert Panel Narrative Review
Lung cancer continues to be the most common cause of cancer-related death worldwide. In the past decade, with the implementation of lung cancer screening programs and advances in surgical and nonsurgical therapies, the survival of patients with lung cancer has increased, as has the number of imaging studies that these patients undergo. However, most patients with lung cancer do not undergo surgical re-section, because they have comorbid disease or lung cancer in an advanced stage at diagnosis. Nonsurgical therapies have continued to evolve with a growing range of systemic and targeted therapies, and there has been an associated evolution in the imaging findings encountered at follow-up examinations after such therapies (e.g., with respect to posttreatment changes, treatment complications, and recurrent tumor). This AJR Expert Panel Narrative Review describes the current status of nonsurgical therapies for lung cancer and their expected and unexpected imaging manifestations. The goal is to provide guidance to radiologists regarding imaging assessment after such therapies, focusing mainly on non-small cell lung cancer. Covered therapies include systemic therapy (conventional chemotherapy, targeted therapy, and immunotherapy), radiotherapy, and thermal ablation.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:221 |
|---|---|
| Enthalten in: |
AJR. American journal of roentgenology - 221(2023), 4 vom: 17. Okt., Seite 409-424 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Murphy, David J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Ablation |
|---|
| Anmerkungen: |
Date Completed 25.09.2023 Date Revised 26.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.2214/AJR.23.29104 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM355993465 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM355993465 | ||
| 003 | DE-627 | ||
| 005 | 20240426233156.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2214/AJR.23.29104 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1388.xml |
| 035 | |a (DE-627)NLM355993465 | ||
| 035 | |a (NLM)37095669 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Murphy, David J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Imaging Follow-Up of Nonsurgical Therapies for Lung Cancer |b AJR Expert Panel Narrative Review |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.09.2023 | ||
| 500 | |a Date Revised 26.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Lung cancer continues to be the most common cause of cancer-related death worldwide. In the past decade, with the implementation of lung cancer screening programs and advances in surgical and nonsurgical therapies, the survival of patients with lung cancer has increased, as has the number of imaging studies that these patients undergo. However, most patients with lung cancer do not undergo surgical re-section, because they have comorbid disease or lung cancer in an advanced stage at diagnosis. Nonsurgical therapies have continued to evolve with a growing range of systemic and targeted therapies, and there has been an associated evolution in the imaging findings encountered at follow-up examinations after such therapies (e.g., with respect to posttreatment changes, treatment complications, and recurrent tumor). This AJR Expert Panel Narrative Review describes the current status of nonsurgical therapies for lung cancer and their expected and unexpected imaging manifestations. The goal is to provide guidance to radiologists regarding imaging assessment after such therapies, focusing mainly on non-small cell lung cancer. Covered therapies include systemic therapy (conventional chemotherapy, targeted therapy, and immunotherapy), radiotherapy, and thermal ablation | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a RECIST | |
| 650 | 4 | |a ablation | |
| 650 | 4 | |a imaging follow-up | |
| 650 | 4 | |a lung cancer | |
| 650 | 4 | |a radiation therapy | |
| 650 | 4 | |a response assessment | |
| 650 | 4 | |a targeted therapy | |
| 700 | 1 | |a Mayoral, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Larici, Anna R |e verfasserin |4 aut | |
| 700 | 1 | |a Ginsberg, Michelle S |e verfasserin |4 aut | |
| 700 | 1 | |a Cicchetti, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Fintelmann, Florian J |e verfasserin |4 aut | |
| 700 | 1 | |a Marom, Edith M |e verfasserin |4 aut | |
| 700 | 1 | |a Truong, Mylene T |e verfasserin |4 aut | |
| 700 | 1 | |a Gill, Ritu R |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t AJR. American journal of roentgenology |d 1981 |g 221(2023), 4 vom: 17. Okt., Seite 409-424 |w (DE-627)NLM000037109 |x 1546-3141 |7 nnns |
| 773 | 1 | 8 | |g volume:221 |g year:2023 |g number:4 |g day:17 |g month:10 |g pages:409-424 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2214/AJR.23.29104 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 221 |j 2023 |e 4 |b 17 |c 10 |h 409-424 | ||